Table of contents
- Executive summary
- 1 Introduction
- 2 Overview of the drug treatment court funding program
- 3 Evaluation methodology
- 4 Findings
- 4.1 Relevance
- 4.2 Design and Delivery
- 4.2.1 Profile of Drug Treatment Court Participants
- 4.2.2 Equitable Access to Drug Treatment Courts
- 4.2.3 Service Utilization and Gaps
- 4.2.4 Underrepresentation among Drug Treatment Courts Participants
- 4.2.5 Responsiveness of Drug Treatment Courts to Identity Factors of Participants
- 4.2.6 Drug Treatment Court Operations
- 4.2.7 Impact of COVID-19
- 4.2.8 Scaling and Expansion
- 4.2.9 Program Reporting Requirements
- 4.2.10 Facilitating Information Sharing
- 4.3 Achievement of Expected Outcomes
- 4.4 Efficiency
- 5 Conclusions and recommendations
- Appendix A: Drug Treatment Court principles
- Appendix B: Evaluation issues and questions
- Appendix C: Evaluation methodology
List of Figures
- Figure 1: Percentage of Drug Treatment Court Participants by Sex, 2015-2021
- Figure 2: Percentage of Drug Treatment Court Participants by Race, 2015-2021
- Figure 3: Rated Effectiveness of Sharing of Lessons Learned Among Drug Treatment Court DTCs
List of Tables
- Table 1: Program Allocated Resources during the Evaluation Period
- Table 2: Observed Trends Related to Drug Treatment Court in the Last 5 Years
- Table 3: Number of Participants Started in Program-Funded Drug Treatment Courts 2015-16 to 2021
- Table 4: Drug Treatment Court Programs and Service Utilization and Gaps (Survey Response)
- Table 5: Impact of COVID-19 on Drug Treatment Courts according to stakeholder survey data
- Table 6: Gs&Cs Program Budget and Expenditures by Category
Report a problem on this page
- Date modified: